repaglinide 0.5 MG Oral Tablet

RxCUI: 200257
RxNorm name: repaglinide 0.5 MG Oral Tablet
Display name: repaglinide 0.5 MG Oral Tablet
Full name: repaglinide 0.5 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Repaglinide	REPAGLINIDE	NorthStar RxLLC	7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665	2025-09-15	Warnings, Adverse reactions	Exact identifier rxcui: 200257
Repaglinide	REPAGLINIDE	Chartwell RX, LLC	cb995e92-295e-4638-a064-978211f5afe1	2025-05-02	Warnings, Adverse reactions	Exact identifier rxcui: 200257
Repaglinide	REPAGLINIDE	Bryant Ranch Prepack	9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173	2025-01-23	Warnings, Adverse reactions	Exact identifier rxcui: 200257
Repaglinide	REPAGLINIDE	Bryant Ranch Prepack	3b150917-e2fd-4366-af83-ebc1d7297ca9	2025-01-16	Warnings, Adverse reactions	Exact identifier rxcui: 200257
Repaglinide	REPAGLINIDE	Aurobindo Pharma Limited	68064989-47ea-4ed5-a20e-43c4ef6ec271	2024-05-14	Warnings, Adverse reactions	Exact identifier rxcui: 200257
Repaglinide	REPAGLINIDE	Rising Pharma Holdings, Inc.	d7673e22-0dbb-4395-ad60-943d249203a1	2024-05-14	Warnings, Adverse reactions	Exact identifier rxcui: 200257
Repaglinide	REPAGLINIDE	Macleods Pharmaceuticals Limited	7a93246c-9323-40c4-b590-a40dcb133c8c	2023-04-04	Warnings, Adverse reactions	Exact identifier rxcui: 200257

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
68064989-47ea-4ed5-a20e-43c4ef6ec271	repaglinide 0.5 MG Oral Tablet	PSN	11	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20240514
68064989-47ea-4ed5-a20e-43c4ef6ec271	repaglinide 0.5 MG Oral Tablet	SCD	11	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20240514
d7673e22-0dbb-4395-ad60-943d249203a1	repaglinide 0.5 MG Oral Tablet	PSN	7	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20240514
d7673e22-0dbb-4395-ad60-943d249203a1	repaglinide 0.5 MG Oral Tablet	SCD	7	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20240514
813f781f-7db8-49ed-b4ed-a829c37eddb7	repaglinide 0.5 MG Oral Tablet	PSN	5	These highlights do not include all the information needed to use PRANDIN safely and effectively. See full prescribing information for PRANDIN. Initial U.S. Approval: 1997	20171228
813f781f-7db8-49ed-b4ed-a829c37eddb7	repaglinide 0.5 MG Oral Tablet	SCD	5	These highlights do not include all the information needed to use PRANDIN safely and effectively. See full prescribing information for PRANDIN. Initial U.S. Approval: 1997	20171228
7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665	repaglinide 0.5 MG Oral Tablet	PSN	2	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250915
7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665	repaglinide 0.5 MG Oral Tablet	SCD	2	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250915
cb995e92-295e-4638-a064-978211f5afe1	repaglinide 0.5 MG Oral Tablet	SCD	1	REPAGLINIDE TABLETS These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250502
cb995e92-295e-4638-a064-978211f5afe1	repaglinide 0.5 MG Oral Tablet	PSN	1	REPAGLINIDE TABLETS These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250502
9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173	repaglinide 0.5 MG Oral Tablet	SCD	1	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250123
9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173	repaglinide 0.5 MG Oral Tablet	PSN	1	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250123
3b150917-e2fd-4366-af83-ebc1d7297ca9	repaglinide 0.5 MG Oral Tablet	PSN	1	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250116
3b150917-e2fd-4366-af83-ebc1d7297ca9	repaglinide 0.5 MG Oral Tablet	SCD	1	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20250116
7a93246c-9323-40c4-b590-a40dcb133c8c	repaglinide 0.5 MG Oral Tablet	SCD	1	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20230404
7a93246c-9323-40c4-b590-a40dcb133c8c	repaglinide 0.5 MG Oral Tablet	PSN	1	These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997	20230404